Paul Hudson

Chief Executive Officer, Sanofi

Joined Sanofi, a global biopharmaceutical company dedicated to transforming scientific innovation into healthcare solutions, as Chief Executive Officer in September 2019. Over 25 years’ experience driving growth and building strong teams for numerous pharmaceutical companies across the United States, Asia and Europe. Starting as a sales representative and ascending to Chief Executive Officer of Novartis Pharmaceuticals before joining Sanofi; known for identifying medicines that can change patients’ lives and commercializing them to full potential. Drove the success of Entresto and the development of Cosentyx, a top-selling treatment of Novartis. Also extended AstraZeneca’s footprint in the oncology field with cancer drugs Tagrisso and Lynparza. Close ties with global innovation hubs led to early adoption of digitization to empower and accelerate R&D while increasing productivity across business functions. Degree in economics; Diploma, Chartered Institute of Marketing. Honorary Doctor of Business Administration, Manchester Metropolitan University. Member of the Board of PhRMA.

最新記事

グローバルな協力体制

増加する交通事故による死者企業取るべき対策

現在世界交通事故による死傷急増おり年間死者130万人負傷者数5,000万人達しますこれ交通インフラ老朽携帯電話など使用による運転注意力散新しい種類モビリティ登場自動車台数過去最大増加いることなど影響ます

2023年09月11日

世界経済フォーラムについて

パートナーとメンバー

  • 参加する

言語

プライバシーポリシーと利用規約

© 2024 世界経済フォーラム